-Reuters
Biokine Therapeutics Ltd., BioLineRx Ltd. Granted U.S. Patent #11554159: Compositions And Methods For Treating Cancer
https://www.scribd.com/document/620316827/BLRX-Patent
Related Posts
AERWINS Technologies Announces 1-For-100 Reverse Stock Split, Effective At The Market Open On April 2, 2024
AERWINS Technologies Inc. (NASDAQ:AWIN) ("AERWINS" or "the Company") today announced that the Company's board of directors has resolved to effectuate a reverse stock split of AERWINS's issued and outstanding common
Templeton Global Income Fund Announces Commencement Of Tender Offer For Its Common Shares; The Fund Will Purchase For Cash Up To 45% Of Its Outstanding Common Shares
Templeton Global Income Fund (NYSE:GIM) (the "Fund"), today announced the commencement of a tender offer for its outstanding common shares.The Fund will purchase for cash up to 45% of its outstanding common shares, no
Morgan Stanley Maintains Equal-Weight on Sempra Energy, Raises Price Target to $162
Morgan Stanley analyst Stephen Byrd maintains Sempra Energy (NYSE:SRE) with a Equal-Weight and raises the price target from $153 to $162.